Graph: Pt Versus Fvii:c (9f903efb 9166 47f1 Abf4 B2180cd5f9f8 03)
Novoseven Kit
Product Images NDC 0169-7201
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 43 technical images submitted to the FDA as part of the official labeling for Novoseven (NDC 0169-7201). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Novo Nordisk, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure A (9f903efb 9166 47f1 Abf4 B2180cd5f9f8 04)
Figure B (9f903efb 9166 47f1 Abf4 B2180cd5f9f8 05)
1 mg. Carton (9f903efb 9166 47f1 Abf4 B2180cd5f9f8 22)
2 mg. Carton (9f903efb 9166 47f1 Abf4 B2180cd5f9f8 23)
5 mg. Carton (9f903efb 9166 47f1 Abf4 B2180cd5f9f8 24)
8 mg. Carton (9f903efb 9166 47f1 Abf4 B2180cd5f9f8 25)
NovoSeven RT is a medication used to treat bleeding episodes in people with hemophilia A or B. It is a recombinant form of factor VIIa, which helps the blood to clot. NovoSeven RT is typically administered during surgery or after an injury to prevent excessive bleeding. It is not available over the counter and must be prescribed by a medical professional.*
2 mL Histidine Syringe.jpg (9f903efb 9166 47f1 Abf4 B2180cd5f9f8 31)
This is a description of a 10 mmol solution of Histidine used for reconstitution of NovoSeven® RT 2 mg. It should be stored between 2-25°C (36-77°F) and has an NDC of 0169-7012-98. There is also a Lot No. of 8-9033-31-201-2 with an Exp. Date listed. This product is only available with a prescription (Rxonly).*
5 mL Histidine Syringe.jpg (9f903efb 9166 47f1 Abf4 B2180cd5f9f8 32)
This is a description of a medicine called Histidine that is used to reconstitute a drug called NovoSeven RT 5 mg. The medicine comes in a 10 mmol solution and has a National Drug Code (NDC) of 0169-7015-98. It should be stored at a temperature between 2-25°C (36-77°F) and requires a prescription to obtain. The text also includes manufacturer/lot number information and an expiration date.*
1 mg. Peel-off Vial Label (9f903efb 9166 47f1 Abf4 B2180cd5f9f8 34)
2 mg. Peel-off Vial Label (9f903efb 9166 47f1 Abf4 B2180cd5f9f8 35)
5 mg. Peel-off Vial Label (9f903efb 9166 47f1 Abf4 B2180cd5f9f8 36)
This is a description of a medication called NovoSeven® RT with the active ingredient Coagulation Factor Vila (Recombinent). It is a room temperature stable medication that is administered through intravenous injection. It should be stored between temperatures of 2-25°C (36-77°F) and reconstituted with 5 mL histidine diluent only. The label indicates that it is for prescription-only use and provides contact information for the manufacturer, Novo Nordisk Inc. There is also an expiration date and lot number provided on the label.*
8 mg. Peel-off Vial Label (9f903efb 9166 47f1 Abf4 B2180cd5f9f8 37)
NOC OO T218-11 is a product by Novo Nordisk Inc called NovoSeven RT. It is a coagulation factor Vil (Recombinant) and is stored at room temperature between 2-25°C (36-77°F). It is meant for bolus intravenous administration and should be reconstituted with 8 mL histidine diluent mentioned as IPLH. The expiration date is mentioned in the form of Lot No. The contact number is provided as 1877:NOVO-777 16.*
1 Vial Of Novoseven Rt Powder And 1 Vial Of Histidine Diluent (Image 01)
This is a description of a diluent vial labelled "Power vl". The vial has a plastic cap and a rubber stopper. There are two sets of plastic caps and rubber stoppers present in the image.*
Novoseven Rt Package Containing 1 Vial Of Powder And 1 Pre-filled Histidine Diluent Syringe With Vial Adapter (Image 02)
2.1 mL Histidine (Image 03)
This is a document related to chemical composition and identification. The document mentions the use of Histidine solution and Novoseven medication. It also provides a code or identification number (Noc 168700298) and some information on storage conditions. The remaining text looks like product information, including expiration date and lot number.*
5.2 mL Histidine (Image 04)
This is a description of a medication product. The product is a 10 mmol solution of Histidine used for the reconstitution of NovoSeven® RT 5 mg. The medication should be stored at a temperature between 2-25°C (36-77°F) and is available only with a prescription. The product is distributed by Novo Nordisk Inc. and the expiration date is mentioned as 8.9316-31:2031.*
1 mL Histidine Syringe (Image 05)
This is a description of a medication called NovoSeven® RT. It requires reconstitution with a 10 mmol solution of Histidine in order to be used. The medication should be stored between 2-25°C (36-77°F) and its NDC (National Drug Code) is 0169-7011-98. There is also a lot number provided by the manufacturer, Novo Nordisk Inc. The text does not provide further information than this.*
1 mg. Vial (Image 06)
This appears to be a product label or packaging information for a medication or solution made by Novo Nordisk Inc. The product is stored at room temperature and is meant for "bels iirvensus sdministration". It is instructed to be stored between 2.25°C and G67T. The product may come with a "cuion with 11 mL" but it is unclear what this means. The text also includes an expiration date (Date/lot no) of 12-31-2021.*
2 mg. Vial (Image 07)
This is a description of a drug with the NDC number 01697027 11 that can be reconstituted using 21 ml dime diluent. The drug is stable at room temperature and is intended for intravenous administration. It should be stored between 2 and 25°C by Novo Nordisk Inc. The expiration date and lot number are also provided.*
5 mg. Vial (Image 08)
This is a description of NovoSeven® RT, a recombinant Coagulation Factor Vila that is room temperature stable. It is administered through bolus intravenous and stored between 2-25°C (36-77°F) following reconstitution with 5.2 mL 2-25°C (36-77°F) histidine diluent only TR. The product comes with an Rx only prescription label and the manufacturer's contact number 1-877-NOVO-777. The expiration date of the product is given as 89014312021.*
1.1 mL Histidine (Image 09)
This is a product label for a solution of Histidine, which is meant to be stored between 2-25°C (36-77°F). The label includes the National Drug Code (NDC) and the manufacturer's information (Novo Nordisk Inc.). The product is meant for reconstitution and is only available with a prescription. The label also provides an expiration date and lot number.*
8 mL Histidine Syringe (Image 10)
This is a product description for Histidine, a 10 mmol solution used to reconstitute NovoSeven RT 8mg. It is only available with a prescription and should be stored between 2-25°C. The text also provides information on the manufacturer, Novo Nordisk Inc., and a lot number, but no discernible expiry date is available.*
Image 11
Image 12
NovoSeven RT is a recombinant coagulation factor used for the treatment of bleeding in patients with hemophilia A or B, or with acquired hemophilia.*
Image 13
NovoSeven® RT is a medication used for the treatment of bleeding in individuals with congenital hemophilia A or B, or who have developed inhibitors to clotting factors VIII or IX. It contains Coagulation Factor VIIa (Recombinant) and is administered intravenously.*
Image 14
NovoSeven® RT is a medication used for treating bleeding episodes and controlling bleeding during surgery. It contains the active ingredient Coagulation Factor VIIa (Recombinant).*
Image 27
This appears to be a list of components included in a package containing NovoSeven® RT powder for injection. The package includes a vial of the powder, a vial adapter, a pre-filled syringe with diluent, a plunger rod, a plastic cap, a protective cap, a rubber plunger, a rubber stopper, a storage paper, and a syringe cap.*
Image 28
Image 29
Image 30
Image 31
Image 32
Image 33
Image 34
Image 35
Image 36
Image 37
Image 38
Image 39
Image 40
Image 41
Image 42
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
